Alpenglow Biosciences

Alpenglow Biosciences, Inc. (formerly Lightspeed Microscopy, Inc.), founded in 2018, is an early-stage, unlisted company focused on accelerating drug development and improving clinical diagnostics through AI-enabled 3D imaging technology. Their platform solution provides new pathological insights with higher accuracy by digitizing entire tissues while keeping samples intact for additional analysis. Alpenglow collaborates with pharmaceutical companies to develop better treatments and uses their patented technology to better understand toxicology, efficacy, and the ranking of potential candidates. Five of the top 10 pharmaceutical companies partner with Alpenglow to expedite development timelines, gain new insights, and improve therapeutic success rates.